Workflow
公司业绩
icon
Search documents
宇通客车:2025年第一季度净利润7.55亿元 同比增长14.91%
news flash· 2025-04-25 10:51
宇通客车(600066)公告,2025年第一季度营收为64.18亿元,同比下降3.00%;净利润为7.55亿元,同 比增长14.91%。 ...
兖矿能源:2025年第一季度净利润27.1亿元 同比下降27.89%
news flash· 2025-04-25 10:41
兖矿能源(600188)公告,2025年第一季度营业收入为303.12亿元,同比下降23.53%;净利润为27.1亿 元,同比下降27.89%。 ...
中国神华:2025年第一季度净利润119.49亿元,同比下降18.0%
news flash· 2025-04-25 09:42
Core Viewpoint - China Shenhua (601088) reported a decline in both revenue and net profit for the first quarter of 2025, indicating potential challenges in its operational performance [1] Financial Performance - The company's operating revenue for Q1 2025 was 69.585 billion yuan, representing a year-on-year decrease of 21.1% [1] - The net profit for the same period was 11.949 billion yuan, showing a year-on-year decline of 18.0% [1]
宝信软件:2025年第一季度净利润4.45亿元,同比下降24.60%
news flash· 2025-04-25 09:03
宝信软件(600845)公告,2025年第一季度营收为25.38亿元,同比下降25.16%;净利润为4.45亿元, 同比下降24.60%。 ...
神州信息:2025年一季度净亏损9294.26万元
news flash· 2025-04-25 07:51
神州信息(000555)公告,2025年第一季度营业收入21.6亿元,同比增长22.13%。净亏损9294.26万 元,去年同期净亏损5645.69万元。 ...
金宏气体:2025年第一季度净利润4400.32万元,同比下降42.47%
news flash· 2025-04-25 07:42
金宏气体公告,2025年第一季度营收为6.23亿元,同比增长5.62%;净利润为4400.32万元,同比下降 42.47%。 ...
派林生物2025年一季报简析:净利润减26.95%,三费占比上升明显
Zheng Quan Zhi Xing· 2025-04-24 22:15
Core Viewpoint - The recent financial report of Palin Biotech (000403) indicates a significant decline in both revenue and net profit for Q1 2025 compared to the same period in 2024, raising concerns about the company's financial health and operational efficiency [1]. Financial Performance - Total revenue for Q1 2025 was 375 million yuan, a decrease of 14.0% year-on-year [1]. - Net profit attributable to shareholders for Q1 2025 was 89.09 million yuan, down 26.95% from the previous year [1]. - The gross profit margin fell to 48.06%, a decline of 6.53% year-on-year [1]. - The net profit margin decreased to 23.74%, down 15.14% compared to the same period last year [1]. - Total expenses (selling, administrative, and financial) amounted to 67.59 million yuan, representing 18.04% of total revenue, an increase of 30.03% year-on-year [1]. Key Financial Ratios - Return on Invested Capital (ROIC) for the previous year was 8.42%, indicating average capital returns [3]. - The net profit margin for the previous year was 28.07%, suggesting high added value in products or services [3]. Shareholder Information - The company has raised a total of 5.241 billion yuan since its listing and has distributed 432 million yuan in dividends, resulting in a dividend-to-financing ratio of 0.08 [3]. - Analysts project that the company's performance for 2025 will reach 887 million yuan, with an average earnings per share of 1.21 yuan [3]. Fund Holdings - The largest fund holding Palin Biotech is the Huazhang Select Mixed Fund, which has reduced its holdings recently [4]. - Other funds, such as E Fund Balanced Growth and E Fund Kexiang Mixed, have maintained or increased their positions in the company [4].
拉卡拉:2024年净利润3.51亿元,同比下降23.26%
news flash· 2025-04-24 15:18
拉卡拉(300773)公告,2024年营业收入57.59亿元,同比下降2.96%。归属于上市公司股东的净利润 3.51亿元,同比下降23.26%。公司拟向全体股东每10股派发现金红利2元(含税),送红股0股(含税),以 资本公积金向全体股东每10股转增0股。 ...
浙江东方:2024年净利润9.36亿元 同比增长74.84%
news flash· 2025-04-24 14:38
浙江东方(600120)公告,2024年营业收入74.59亿元,同比下降51.70%。归属于上市公司股东的净利 润9.36亿元,同比增长74.84%。向全体股东每10股派发现金红利0.84元(含税)。 ...
华电能源:2025年第一季度净利润4.77亿元,同比增长12.94%
news flash· 2025-04-24 13:46
Group 1 - The core point of the article is that Huadian Energy (600726) reported a revenue of 5.157 billion yuan in the first quarter of 2025, which represents a year-on-year decrease of 3.70% [1] - The net profit for the same period was 477 million yuan, showing a year-on-year increase of 12.94% [1]